The TLR2/NF-κB pathway in PAECs likely mediates downstream inflammatory responses induced by reduced compliance of upstream vessels which are less capable of dampening HPF, and thus TLR2 might be a potential target for endothelial inflammation of pulmonary hypertension. This evidence concerns the gene TLR2 and pulmonary arterial hypertension.